The role of hemorheological factors in cardiovascular medicine

Clinical Hemorheology and Microcirculation

Volumn 56, Issue 3, 2014, Pages 197-204

  Toth, A ^a   Papp, J ^a   Rabai, M ^a,b   Kenyeres, P ^a   Marton, Zs ^a   Kesmarky, G ^a   Juricskay, I ^a   Meiselman, H J ^b   Toth, K ^a,b  

^a UNIVERSITY OF PÉCS   (Hungary)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

acute coronary syndrome; coronary artery bypass grafting; ethanol; hematocrit per blood viscosity ratio; Ischemic heart disease; percutaneous coronary intervention; red wine

Indexed keywords

ACUTE CORONARY SYNDROME; ARTICLE; BLOOD RHEOLOGY; CARDIOVASCULAR DISEASE; CHRONIC DISEASE; CORONARY ARTERY BYPASS GRAFT; FOLLOW UP; HEART DEATH; HEMATOLOGICAL PARAMETERS; HEMORHEOLOGICAL PARAMETER; HUMAN; HUMAN CELL; ISCHEMIC HEART DISEASE; PERCUTANEOUS CORONARY INTERVENTION; RED WINE; RISK FACTOR; BLOOD; BLOOD VISCOSITY; DRUG EFFECTS; FEMALE; HEART MUSCLE ISCHEMIA; MALE; PATHOPHYSIOLOGY;

BLOOD VISCOSITY; CARDIOVASCULAR DISEASES; FEMALE; HEMORHEOLOGY; HUMANS; MALE; MYOCARDIAL ISCHEMIA; RISK FACTORS;

EID: 84901801220     PISSN: 13860291     EISSN: 18758622     Source Type: Journal    
DOI: 10.3233/CH-131685     Document Type: Article

References (26)

1. L. Bogar, I. Juricskay, G. Kesmarky, P. Kenyeres and K. Toth, Erythrocyte transport efficacy of human blood: A rheological point of view, Eur J Clin Invest 35 (2005), 687-690.
2. H.K. Breddin, Can platelet aggregometry be standardized? Platelets 16 (2005), 151-158.
3. C. Carter, D. McGee, D. Reed, K. Yano and G. Stemmermann, Hematocrit and the risk of coronary heart disease: The Honolulu heart program, Am Heart J 105 (1983), 674-679.
4. G. de Gaetano, M. Crescente and C. Cerletti, Current concepts about inhibition of platelet aggregation, Platelets 19 (2008), 565-570.
5. W.B. Kannel, R.B. D'Agostino and A.J. Belanger, Fibrinogen, cigarette smoking, and risk of cardiovascular disease: Insights from the Framingham study, Am Heart J 113 (1987), 1006-1010.
6. P. Kenyeres, I. Juricskay, P. Tarsoly, G. Kesmarky, D. Mühl, K. Toth and L. Bogar, Low hematocrit per blood viscosity ratio as a mortality risk factor in coronary heart disease, Clin Hemorheol Microcirc 38 (2008), 51-56.
7. G. Kesmarky, K. Toth, L. Habon, G. Vajda and I. Juricskay, Hemorheological parameters in coronary artery disease, Clin Hemorheol Microcirc 18 (1998), 245-251.
8. G. Kesmarky, K. Toth, G. Vajda, L. Habon, R. Halmosi and E. Roth, Hemorheological and oxygen free radical associated alterations during and after percutaneous transluminal coronary angioplasty, Clin Hemorheol Microcirc 24 (2001), 33-41.
9. W. Koenig and E. Ernst, The possible role of hemorheology in atherothrombogenesis, Atherosclerosis 94 (1992), 93-107.
10. A.J. Lee, P.I. Mowbray, G.D.O. Lowe, A. Rumley, F.G.R. Fowkes and P.L. Allan, Blood viscosity and elevated carotid intima-media thickness in men and women. The Edinburgh artery study, Circulation 97 (1998), 1467-1473.
11. G.D.O. Lowe, F.G.R. Fowkes, J. Dawes, P.T. Donnan, S.E. Lennie and E. Housley, Blood viscosity, fibrinogen, and activation of coagulation and leukocytes in peripheral arterial disease and the normal population in the Edinburgh artery study, Circulation 87 (1993), 1915-1920.
12. J. Ma, C.H. Hennekens, P.M. Ridker and M.J. Stampfer, A prospective study of fibrinogen and risk of myocardial infarction in the physicians' health study, J Am Coll Cardiol 33 (1999), 1347-1352.
13. Zs Marton, B. Horvath, T. Alexy, G. Kesmarky, Zs. Gyevnar, L. Czopf, T. Habon, L. Kovacs, E. Papp, B. Mezey, E. Roth, I. Juricskay and K. Toth, Follow-up of hemorheological parameters and platelet aggregation in patients with acute coronary syndromes, Clin Hemorheol Microcirc 29 (2003), 81-94.
14. J. Papp, A. Toth, B. Sandor, R. Kiss, M. Rabai, P. Kenyeres, I. Juricskay, G. Kesmarky, S. Szabados and K. Toth, The infiuence of on-pump and off-pump coronary artery bypass grafting on hemorheological parameters, Clin Hemorheol Microcirc 49 (2011), 331-346.
15. M. Rabai, A. Toth, P. Kenyeres, L. Mark, Zs Marton, I. Juricskay, K. Toth and L. Czopf, In vitro hemorheological effects of red wine and alcohol-free red wine extract, Clin Hemorheol Microcirc 44 (2010), 227-236.
16. M. Rabai, J.A. Detterich, R.B. Wenby, K. Toth and H.J. Meiselman, Effects of ethanol on red blood cell rheological behaviour, Clin Hemorheol Microcirc (2012). [Epub ahead of print].
17. P.M. Sweetnam, H.F. Thomas, J.W.G. Yarnell, A.D. Beswick, I.A. Baker and P.C. Elwood, Fibrinogen, viscosity and the 10-year incidence of ischemic heart disease: The Caerphilly and Speedwell studies, Eur Heart J 17 (1996), 1814-1820.
18. A. Toth, B. Sandor, J. Papp, M. Rabai, D. Botor, Zs. Horvath, P. Kenyeres, I. Juricskay and K. Toth, Moderate red wine consumption improves hemorheological parameters in healthy volunteers, Clin Hemorheol Microcirc (2012). [Epub ahead of print]
19. K. Toth, B. Mezey, I. Juricskay and T. Javor, Hemorheological changes during the hospital phase of acute myocardial infarction: Sex differences? Med Sci Res 17 (1989), 841-844.
20. K. Toth, T. Habon, I. Horvath, B. Mezey, I. Juricskay and Gy. Mozsik, Hemorheological and hemodynamical parameters in patients with ischemic heart disease at rest and at peak exercise, Clin Hemorheol 14 (1994), 329-338.
21. K. Toth, L. Bogar, I. Juricskay, M. Keltai, S. Yusuf, L.J. Haywood and H.J. Meiselman, The effect of RheothRx Injection on the hemorheological parameters in patients with acute myocardial infarction, Clin Hemorheol Microcirc 17 (1997), 117-125.
22. K.Toth and G.Kesmarky, Clinical Significance of Hemorheological Alterations, in: Handbook of Hemorheology and Hemodynamics. O.K. Baskurt, M.R. Hardeman, M.W. Rampling and H.J. Meiselman, eds., IOS Press: Amsterdam, Netherlands, 2007. pp. 392-432.
23. A. Vaya, M. Martinez, J. Dalmau, M. Labios and J. Aznar, Hemorheological profile in patients with cardiovascular risk factors, Haemostasis 26 (1996), 1666-1670.
24. D.G. Yanbaeva, M.A. Dentener, E.C. Creutzberg, G.Wesseling and E.F.Wouters, Systemic effects of smoking, Chest 131 (2007), 1557-1566.
25. J.W. Yarnell, I.A. Baker, P.M. Sweetnam, D. Bainton, J.R. O-Brien, P.J. Whitehead and P.C. Elwood, Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease. The Caerphilly and Speedwell collaborative heart disease studies, Circulation 83 (1991), 836-844.
26. S. Yusuf, S. Reddy, S. Ounpuu and S. Anand, Global burden of cardiovascular diseases: Part I: General considerations, the epidemiologic transition, risk factors, and impact of urbanization, Circulation 104 (2001), 2746-2753.